We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Macrogen

News List

AVATAMED and Macrogen sign MOU on joint business in personalized precision medicine services in cancer treatment prnasia
October 30, 2020
AVATAMED, a precision medicine service company based in Singapore, represented by CEO Mr. Hong Boon Toh, has entered into a business agreement on 29 October 2020 with Macrogen, a biotechnology company in precision medicine headquartered in South Korea ...
Macrogen, Exosome Plus to jointly develop exosome-based diagnostic & treatment solutions biospectrumasia
April 25, 2019
Under the newly signed contract, Exosome Plus will exclusively supply its high-efficiency exosome isolation kit ‘Exo2D' to Macrogen for one year.
Macrogen receives CAP accreditation in two clinical labs in Korea biospectrumasia
August 15, 2018
Expected to Expand the Clinical Diagnostics Market in Korea and Accelerate Entry into the Global Market